Custom-tailored single-domain antibody discovery services

We are known for the quality of our in-house developed and validated state-of-the-art single-domain antibodies (sdAbs). Benefit from our experience and get in touch with our experienced scientists to realize your sdAb project.

Contact

New

FluoTag® JF635b: A novel FluoTag® variant for simplified and precise SMLM

Discover new fluorescent sdAb variant for precise and simplified SMLM: FluoTag® conjugated to Janelia Fluor® - a self-blinking fluorophore that cycles automatically between OFF and ON states. Say goodbye to buffer optimization – get spontaneous blinking right in PBS!

Learn more

Explore our innovative sdAb products

Browse our Shop to discover new sdAb developments and explore our thoroughly-validated products. NanoTag's sdAb-based solutions are tailored to make your research and development faster, more precise, and reproducible.

FluoTags®

One-step enhanced immunofluorescence

View

Smart Secondaries®

Flexible, simple, and precise detection of primary antibodies

View

Selector Resins

High-performance pulldowns

View

Camelid sdAb

Novel scaffolds beyond your imagination with unlimited applications

View

Single-domain antibodies tailored to your needs

We are looking forward to working with you

CRO Services

We provide highly customized services for your project. From protein production, advanced modifications of sdAbs, functional validations, and the discovery of specific sdAbs tailored to your needs.

Learn more

Our Technology

At NanoTag, we have developed several new technologies and patented innovations resulting in unique biological tools ready to be applied in R&D.

Learn more

Pipeline

NanoTag's discovery program to generate and characterize novel single-domain antibodies directed against specific targets with high potential in therapeutic applications.

Learn more

Superior affinity reagents for R&D and pre-clinical studies

Our goal is to provide high-quality recombinant affinity molecules supporting therapeutic and diagnostic industries and to create superior, sustainable, and more reproducible reagents for biomedical research.

Learn more